Recent studies have also revealed that an increase in expression levels and transcriptional activity of HIF-1α and HIF-2α frequently occur in PC cells during primary PC progression and bone metastases and is associated with treatment resistance and a poor outcome of patients [1, 4, 9, 13, 101, 195–200]. This evidence concerns the gene EPAS1 and pachyonychia congenita.